Growth Metrics

Vanda Pharmaceuticals (VNDA) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $1.7 million.

  • Vanda Pharmaceuticals' Amortizatization of Intangibles fell 256.85% to $1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.1 million, marking a year-over-year decrease of 356.85%. This contributed to the annual value of $7.0 million for FY2025, which is 365.74% down from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $1.7 million for Q4 2025, which was down 256.85% from $1.8 million recorded in Q3 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $2.3 million in Q1 2023 and a low of -$490000.0 during Q1 2021
  • Over the past 5 years, Vanda Pharmaceuticals' median Amortizatization of Intangibles value was $1.7 million (recorded in 2023), while the average stood at $1.1 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 22250.0% in 2021, then soared by 101060.61% in 2022.
  • Vanda Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$198000.0 in 2021, then soared by 1010.61% to $1.8 million in 2022, then decreased by 3.16% to $1.7 million in 2023, then rose by 0.34% to $1.8 million in 2024, then decreased by 2.57% to $1.7 million in 2025.
  • Its Amortizatization of Intangibles was $1.7 million in Q4 2025, compared to $1.8 million in Q3 2025 and $1.8 million in Q2 2025.